NasdaqGS - Nasdaq Real Time Price USD
Atea Pharmaceuticals, Inc. (AVIR)
2.8500
-0.0200
(-0.70%)
At close: April 23 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 545,600 | 13 |
| Sales | 359,606 | 1 |
| Net Shares Purchased (Sold) | 185,994 | 14 |
| Total Insider Shares Held | 9.97M | -- |
| % Net Shares Purchased (Sold) | 1.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CORCORAN ANDREA J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| CORCORAN ANDREA J Officer | -- | Direct | -- | Jan 31, 2025 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | -- | Direct | -- | Jan 31, 2025 |
| FOSTER WAYNE CPA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| FOSTER WAYNE CPA Officer | -- | Direct | -- | Jan 31, 2025 |
| HORGA MARIA ARANTXA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| HORGA MARIA ARANTXA Officer | -- | Direct | -- | Jan 31, 2025 |
| HAMMOND JANET MJ Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| HAMMOND JANET MJ Officer | -- | Direct | -- | Jan 31, 2025 |
| VAVRICKA JOHN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| VAVRICKA JOHN Officer | -- | Direct | -- | Jan 31, 2025 |
| BERGER FRANKLIN MILAN Director | Purchase at price 3.19 - 3.36 per share. | Direct | 81,498 | Jan 16, 2025 |
| BERGER FRANKLIN MILAN Director | Sale at price 2.85 per share. | Direct | 1,023,475 | Dec 10, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 4.00 - 4.05 per share. | Indirect | 234,155 | Sep 19, 2024 |
| POLSKY BRUCE Director | Sale at price 3.49 per share. | Direct | 61,144 | Jun 20, 2024 |
| DUNCAN BARBARA GAYLE Director | -- | Direct | -- | Jun 14, 2024 |
| BERGER FRANKLIN MILAN Director | -- | Direct | -- | Jun 14, 2024 |
| POLSKY BRUCE Director | -- | Direct | -- | Jun 14, 2024 |
| LUCIDI BRUNO Director | -- | Direct | -- | Jun 14, 2024 |
| MURPHY POLLY A Director | -- | Direct | -- | Jun 14, 2024 |
| ADAMS JEROME M. M.D. Director | -- | Direct | -- | Jun 14, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 4.00 per share. | Indirect | 4,024 | Jun 5, 2024 |
| CORCORAN ANDREA J Chief Financial Officer | Sale at price 3.84 per share. | Direct | 60,915 | Feb 1, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | Sale at price 3.84 per share. | Direct | 218,819 | Feb 1, 2024 |
| FOSTER WAYNE CPA Officer | Sale at price 3.84 per share. | Direct | 47,904 | Feb 1, 2024 |
| HORGA MARIA ARANTXA Officer | Sale at price 3.84 per share. | Direct | 60,963 | Feb 1, 2024 |
| HAMMOND JANET MJ Officer | Sale at price 3.84 per share. | Direct | 53,913 | Feb 1, 2024 |
| VAVRICKA JOHN Officer | Sale at price 3.84 per share. | Direct | 45,420 | Feb 1, 2024 |
| CORCORAN ANDREA J Chief Financial Officer | -- | Direct | -- | Jan 31, 2024 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | -- | Direct | -- | Jan 31, 2024 |
| FOSTER WAYNE CPA Officer | -- | Direct | -- | Jan 31, 2024 |
| HORGA MARIA ARANTXA Officer | -- | Direct | -- | Jan 31, 2024 |
| HAMMOND JANET MJ Officer | -- | Direct | -- | Jan 31, 2024 |
| VAVRICKA JOHN Officer | -- | Direct | -- | Jan 31, 2024 |
| BERGER FRANKLIN MILAN Director | Sale at price 5.15 - 5.16 per share. | Direct | 214,685 | Nov 14, 2022 |
| MURPHY POLLY A Director | Purchase at price 8.57 per share. | Direct | 102,796 | Dec 20, 2021 |
| BERGER FRANKLIN MILAN Director | Purchase at price 24.00 per share. | Direct | 999,984 | Nov 3, 2020 |
| BERGER FRANKLIN MILAN Director | -- | Direct | -- | Nov 3, 2020 |
| CORCORAN ANDREA J General Counsel | -- | Direct | -- | Nov 3, 2020 |
| SOMMADOSSI JEAN-PIERRE Chief Executive Officer | -- | Indirect | -- | Nov 3, 2020 |
| ROCK SPRINGS CAPITAL MANAGEMENT, L P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 24.00 per share. | Indirect | 6,000,000 | Nov 3, 2020 |
| ROCK SPRINGS CAPITAL MANAGEMENT, L P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| HACK ANDREW A. F. Director | Purchase at price 24.00 per share. | Indirect | 6,000,000 | Nov 3, 2020 |
| HACK ANDREW A. F. Director | -- | Indirect | -- | Nov 3, 2020 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Nov 3, 2020 |
| CHU CHUNG K. Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Nov 3, 2020 |
| MURPHY POLLY A Director | -- | Indirect | -- | Nov 3, 2020 |
| VAVRICKA JOHN Officer | -- | Indirect | -- | Nov 3, 2020 |
Related Tickers
COYA Coya Therapeutics, Inc.
6.56
-1.20%
TCRX TScan Therapeutics, Inc.
1.6300
+3.82%
ANTX AN2 Therapeutics, Inc.
1.2700
-3.05%
VNDA Vanda Pharmaceuticals Inc.
4.3300
-1.81%
HLVX HilleVax, Inc.
1.8600
+4.49%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%
HOOK HOOKIPA Pharma Inc.
0.7800
+4.00%
XBIT XBiotech Inc.
3.1600
+1.28%
TIL Instil Bio, Inc.
20.52
+24.44%
ELEV Elevation Oncology, Inc.
0.3788
+1.83%